
Tumor-Specific Panels analyze clinically relevant DNA and RNA variants associated with specific cancer types, enabling a comprehensive evaluation of the tumor’s molecular profile. The resulting genomic insights support the selection of personalized, targeted treatment strategies and contribute to informed clinical decision-making.
| Feature | Details |
|---|---|
| Sample | FFPE (Tumor tissue) *(Bone marrow / blood samples for hematological panels) |
| Method | NGS (Next-Generation Sequencing) |
| Coverage | DNA / RNA |
| Variants | SNV, Indel, CNV, Fusion |
| Duration | 18 Days |
19 Mayıs Mah. Çoruh Sok. No:32/1 Fulya, 34394 Şişli / Istanbul, Turkey
Monday - Friday 09:00 - 18:00 Saturday 09:00 - 14:00